A new paper analyzes whether the EU AI Act adequately covers advanced biological foundation models like ESM3. The authors argue that providers of such models should be subject to obligations to assess and mitigate dual-use risks. However, their analysis concludes that ESM3 currently does not appear to be meaningfully regulated by the Act, and they propose remedies to address this gap. AI
Summary written by gemini-2.5-flash-lite from 1 source. How we write summaries →
IMPACT Highlights potential regulatory gaps for advanced AI models, particularly in the biological domain, prompting discussion on future policy adjustments.
RANK_REASON The cluster contains an academic paper analyzing the regulatory implications of AI models under existing legislation. [lever_c_demoted from research: ic=1 ai=1.0]